Joshua Brody, Director of Lymphoma Immunotherapy Program at Icahn School of Medicine at Mount Sinai, shared on LinkedIn:
“Pretty excited to represent Mount Sinai Health System to speak and learn about lymphoma immunotherapy tomorrow with NY superstars BPro – amoCRM – Bitrix24, Bernardo Da Silva, CHER HE researchers.”
Other articles about Lymphoma on OncoDaily.